By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

Contact Information

Website: www.pharvaris.com
Email: info@pharvaris.com
Main Phone: +31 712036410
Address: J.H. Oortweg 21
City / Town: Leiden
Country: NL
Postal Code: 2333 CH

Issuer Information

Exchange: NGS
CEO: Berndt Modig
Employees: 14

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A